Patents by Inventor Jane Lundbeck

Jane Lundbeck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Heteroaryl-ureas and their use as glucokinase activators
    Publication number: 20070054897
    Abstract: This invention relates to compounds of formula (I) which are activators of glucokinase and thus may be useful for the management, treatment, control, or adjunct treatment of diseases, where increasing glucokinase activity is beneficial.
    Type: Application
    Filed: June 14, 2006
    Publication date: March 8, 2007
    Applicant: Novo Nordisk A/S
    Inventors: Anthony Murray, Jesper Lau, Lone Jeppesen, Per Vedso, Michael Ankersen, Jane Lundbeck, Marit Kristiansen, Maria Valcarce-Lopez, Dharma Polisetti, Govindan Subramanian, Robert Andrews, Daniel Christen, Jeremy Cooper, Kalpathy Santhosh
  • Heterocyclic compounds that are inhibitors of the enzyme DPP-IV
    Publication number: 20050148606
    Abstract: The present invention relates to therapeutically active and selective inhibitors of the enzyme DPP-IV of formula I, pharmaceutical compositions comprising the compounds and the use of such compounds for and the manufacture of medicaments for treating diseases that are associated with proteins that are subject to inactivation by DPP-IV, such as type 2 diabetes and obesity.
    Type: Application
    Filed: March 2, 2005
    Publication date: July 7, 2005
    Inventors: Anders Kanstrup, Christian Sams, Jane Lundbeck, Lise Christiansen, Marit Kristiansen